🇺🇸 Supportive care in United States
15 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 15
Most-reported reactions
- Anaemia — 2 reports (13.33%)
- Chest Discomfort — 2 reports (13.33%)
- Hyperhidrosis — 2 reports (13.33%)
- Infection — 2 reports (13.33%)
- Thrombocytopenia — 2 reports (13.33%)
- Abdominal Pain Upper — 1 report (6.67%)
- Acute Myeloid Leukaemia — 1 report (6.67%)
- Arteriospasm Coronary — 1 report (6.67%)
- Chills — 1 report (6.67%)
- Confusional State — 1 report (6.67%)
Other Oncology approved in United States
Frequently asked questions
Is Supportive care approved in United States?
Supportive care does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Supportive care in United States?
Muhammad Aamir Latif is the originator. The local marketing authorisation holder may differ — check the official source linked above.